Study S000343

A Randomized Controlled Trial Comparing the Safety and Efficacy of IDegLira Versus Basal Bolus in Patients With Poorly Controlled Type 2 Diabetes

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT03737240
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 145
Start: 2019-01-15
Primary completion: 2022-07-08
Lead sponsor: Emory University
Conditions: Diabetes Mellitus
Interventions: DRUG:IDegLira; DRUG:Insulin Degludec (U-100); DRUG:Insulin Aspart
Results posted: TRUE

Registered primary outcomes

Change in Hemoglobin A1c (HbA1c) [Baseline, Week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.